Follow Us:


Organised By
Cooperation
Joint Sponsor
Exhibition Sponsor
Keynote Sponsor
Package Sponsor
Insert Sponsor
Advertising Sponsor
Sponsorship
For Sponsorship Opportunities, Please Contact
Heron Zhuang
Delegate Sales Manager
Mobile: 13817472390
Tel: +86-21-61573928
Email: Heron.zhuang@ubm.com

Julia Zhu
Mobile: 13795260497
Tel: +86-21-6157 3922
Email: Julia.Zhu@ubm.com
UBM Conferences
Speakers
 
 
Shaohong Jin
Shaohong Jin
Vice President
National Institutes for Food and Drug Control
Weiping Li
Weiping Li
Sr. Director of Regulatory Affairs
Xian Janssen
Mufeng Xie
Mufeng Xie
Associate chief pharmacist
Shanghai Institutes for Food and Drug Control
Joseph Cho
Joseph Cho
President
RDPAC, Former General Manager of Astellas
Bo Wang
Bo Wang
Researcher
National Drug Policy & Economic Research Center (NDPE)
Zhijun Jiang
Zhijun Jiang
Chairman&President
PharmaMax
Allan Riting Liu
Allan Riting Liu
Vice President/ Senior Advisor
Wanbang Biopharmaceuticals/Fosun Pharma Group
Nicola Travierso
Nicola Travierso
General Manager
NTC Pharma
Gurpreet Sandhu
Gurpreet Sandhu
General Manager
REVA Pharma
Xueming Xu
Xueming Xu
General Manager
Shanghai Seanpharma
Jeannie Zhang
Jeannie Zhang
National "one thousand program" distinguished experts
National "one thousand program"
Dr. Lily Han
Dr. Lily Han
General Manager
Tasly VC investment and International Department
Jianqi Li
Jianqi Li
Researcher
Director of Shanghai Pharmaceutical Industry Research Institute-Chemical Technology Center/Director of Shanghai Engineering Research Center for Drug Synthesis Process
Cathy Wang
Cathy Wang
APAC Marketing Director
Colorcon China
Wengfeng Wang
Wengfeng Wang
Vice General Manager
China Resource Saike Pharmaceutical
Xiaodi Guo
Xiaodi Guo
VP
Huahai US
Guangcheng Pan
Guangcheng Pan
Senior Vice Chairman
China Pharmaceutical Industry Association
Han Jun
Han Jun
General Manager
SOTA Pharmaceutical Inc.
 
 

More exclusive sponsor opportunities, please CLICK HERE
Background and Key Topics
China is changing from a big country to a powerful country in generics industry and there are lots of opportunities in this shift:
  • Generics market continues to flourish, the global growth reached at 8% and in China it achieved at 25%.
  • Pricing policy from NDRC and tender offer from health planning committee to generics which get through generics consistency evaluation.
  • Diversified development of generics market, M&A of pharmacy, strategic cooperation and generics branding
  • Biosimilar is on emerging market, more pharmaceutical companies are involved in biosimilar business……
At the same time, generics companies also face up with many challenges in the increasingly competitive market environment:
  • Stricter of regulation from FDA&EU, the requirement of generics registration and application become higher
  • More types of generics are included in generics consistency evaluation, generics quality requirements gradually improve
  • High standard of generics brings about price fall of terminal product and cost raise, cost inflation is obvious for generics pharmacy
  • Impurity control and dissolution rate comparing are still two big technological difficulties for generics
  • More innovator pharma manufacturers march into generics, pharma IP become deeply and more requirements for formulation development……
The 4th NEXTGEN CHINA 2014 will gather all resource of CPhI global and essence of past three conferences, and explore regulatory, market & technology in generics to discuss and showcase evolving generics landscape & solutions.
Compelling Reasons to Attend
  • Delving into key trends of generics regulatory, market and technology
  • Hearing in-depth presentations from 25+ global speakers under CPhI resources
  • Covering 3 hot topics: updated regulatory environment, ever-changing market and alliance, evolving technology and commercialization
  • Networking with and 120+ decision makers from pharmaceutical companies
  • Benefiting from case studies from leading generic pharmacy of US, EU and India
  • 15+ professional presentations and 2+ panel discussion, getting on-spot answers to your critical business and technical challenges
Past Review
On-site pictures:

Past attendees' comments:
2-day conference made me in deeper understanding of China generics technology dynamics and networking with many industrial professionals and peers.
-- Zhao Xiaowei, Project Manager, FERGUSON.
Getting to acquire generics impurity spectrum technical qualifications, the assessment of generics consistency, USP Pharmacopoeia knowledge.
-- Zhang Suoqing, R&D Manager, North China Pharmaceutical
Getting to know the latest standards for domestic pharmaceutical research progressing.
-- Zhu Dequan, Assistant President/BD Director, SICHUAN HUIYU PHARMACEUTICAL CO., LTD.

Past Participants Analysis:

Manager
Director
General Manager
Vice General Manager
Executive
Specilist
VP
Minister
Dean
Chief Engineer
CEO
Senior Manager
Project Manager
Chief Scientis
Business Development
Product Development
R&D
Technical Department
Sales Department
Marketing Department
Regulatory Affairs
QA/QC
Pharmaceutical Development
IPR
laboratory
Generic Manufacturers
Innovator Pharma Manufacturers
Ingredient and Material Suppliers
Biopharma Manufacturers
CRAMS
Machinery Manufacturers
Drug Delivery Platform Providers
Analytical Laboratories
Life Sciences Companies
Government agencies
Who Should Attend?
Decision makers/R&D/QA,QC/Product Development/Regulatory Affairs/BD/Marketing
From: Generics Manufacturers/Innovator Pharma Manufacturers/CRO,CMO/Ingredient & Material Suppliers/Equipment Suppiers/Government Associations/Analytical Laboratories
Media Partners